News

MMR said that these antibody assets may be used in the development of future treatment options for various autoimmune and B-Cell mediated diseases, which could include lupus nephritis,

Xerecept is an investigational new drug that may present an alternative to dexamethasone for patients with primary and metastatic brain tumors. Xerecept has shown in Phase II and

Comparing treatment with the Delcath PHP System with melphalan to Best Alternative Care (BAC), based on independent core lab review of patient scans, the statistical analysis revealed that

Medtronic Complete SE Vascular Stent System features several advances, including a dual-deployment delivery system with a triaxial design. The new delivery system is made up of an inner

The issued patent covers Mystic Pharmaceuticals’ proprietary unit dose blister technology for packaging of drugs or biologics that have been freeze dried to powder form to improve stability,

Sinclair Pharmacy is expected to work in conjunction with Syntopix to develop a product. Should the collaboration result in a product that reaches commercialisation, financial gains from the

BSD said that the clinical study data will be presented by Rudiger Wessalowski, associate professor at the Clinic of Pediatric Hematology and Oncology, Heinrich-Heine University, Dusseldorf, Germany, at

Vical has reported that TransVax cytomegalovirus (CMV) vaccine elicited sustained increases in both cellular and antibody immune responses compared with placebo TransVax is a bivalent DNA vaccine containing

Michael Pearson, chairman and CEO of Vale ant Pharmaceuticals, said: “This latest transaction, along with Valeant’s acquisition of Institutor Terapeutico Delta last month, will be our second acquisition